Heparin contaminant identified

March 19, 2008 8:35:10 AM PDT
The FDA moved even closer to saying that blood-thinner caused nearly 2 dozen deaths was intentionally counterfeited. Dr. Janet Woodcock says a contaminant in the heparin, processed by Baxter Corporation of Cherry Hill, New Jersey, has been identified as over-sulfated chondroitin sulfate. According to Dr. Woodcock, the compund has to be manufactured in the lab, and does not belong in heparin. But the agency stopped just short of accusing the Chinese supplier of the raw heparin of creating a counterfeit ingredient.

Load Comments